Início > All categories> Biochemicals and Pharmaceutical Chemicals> Pharmaceutical Impurities> (6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

Obter o preço mais recente >

Preço fob contact us for price

Origem: China

Cas No: 104632-28-2

Especificação: 99%Min

Quantidade de ordem min: 1 /kg

Capacidade de fornecimento: 100 mt/month

Tempo de espera: 7 dias para OEM, 3 dias para produtos prontos

Fornecedor:

Condições de pagamento:

Inquérito agora

* Envie um inquérito para nós

Adicionar a lista de desejos

* Diga seu preço
* Iniciar o pedido não significa comprar agora

Especificação de produtos
Descrição do produto

Property

CAS No.: 104632-28-2 Formula: C10H19Cl2N3S Molecular Weight: 284.24900

Description

Dexpramipexole (KNS-760704) is a drug that was investigated by Knopp Biosciences and Biogen Idec for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The drug failed to show efficacy in terms of function or survival in a Phase III study of patients with ALS.
In September 2009, dexpramipexole received Fast Track designation for ALS from the U.S. Food and Drug Administration (FDA). It has received Orphan Drug designation by both the FDA and the European Medicines Agency. Dexpramipexole is a low molecular weight, water-soluble, orally bioavailable, renally excreted compound with linear pharmacokinetics, and has been shown to be well tolerated in human subject testing.
KNS-760704 is the enantiomer of pramipexole, and has been shown to improve mitochondrial function and to confer significant cellular protection in neurons under stress. KNS-760704 was originally identified as a candidate therapy for ALS by James Bennett, M.D., Ph.D., then of the University of Virginia.
A 2010 Phase II clinical trial involving 102 patients showed a slowing of ALS disease progression.
In January 2013, Biogen Idec announced that it was discontinuing its development of dexpramipexole in ALS due to lack of efficacy in a Phase III study.

Basic Info

Chemical Name	(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
Synonyms	Pramipexole [USAN:INN]; (R)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine; (6R)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole; (R)-Pramipexole Dihydrochloride; Dexpramipexole; (6R)-4,5,6,7-tetrahydro-N6-propylbenzothiazole-2,6-diamine; (R)-(+)-2-amino-4,5,6,7-tetrahydro-6-(n-propylamino)benzothiazole;
CAS No.	104632-28-2
Molecular Formula	C10H19Cl2N3S
Molecular Weight	284.24900
PSA	83.52000
LogP	4.38490

Properties

Melting Point	270-272ºC

Safety Info

HS Code	2934999090

Synthesis Route

D-tartaric acid+S(-)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole→(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine+pramipexole
S(-)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole→(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine+pramipexole
(R)-(+)-2-amino-4,5,6,7-tetrahydro-6-(n-propylamino)benzothiazole p-toluenesulfonic acid→(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

Precursor

D-tartaric acid
S(-)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole
(R)-(+)-2-amino-4,5,6,7-tetrahydro-6-(n-propylamino)benzothiazole p-toluenesulfonic acid
N-[(6R)-2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]propanamide

Hot tags: (6r)-6-n-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, China, fabricantes, fornecedores, fábrica, atacado, baixo preço, alta qualidade